UCN-01 selectively enhances mitomycin C-cytotoxicity in p53 defective cells which is mediated through S and/or G2 checkpoint abrogation.

被引：0
|
作者：
Sugiyama, K
Shimizu, M
Akiyama, T
Tamaoki, T
Inoue, K
Yamaguchi, K
Takahashi, R
Eastman, A
Akinaga, S
机构：
[1] Kyoto Univ, Kyoto, Japan
[2] Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res Labs, Tokyo, Japan
[3] Natl Canc Ctr, Res Inst, Grad Sch Med, Tokyo, Japan
[4] Dartmouth Med Sch, Hanover, NH USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：3753S / 3754S
页数：2
相关论文
共 24 条
  • [1] UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G2 checkpoint abrogation
    Sugiyama, K
    Shimizu, M
    Akiyama, T
    Tamaoki, T
    Yamaguchi, K
    Takahashi, R
    Eastman, A
    Akinaga, S
    INTERNATIONAL JOURNAL OF CANCER, 2000, 85 (05) : 703 - 709
  • [2] Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
    Shao, RG
    Cao, CX
    Pommier, Y
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (06) : 756 - 762
  • [3] Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells
    Yves POMMIER
    ActaPharmacologicaSinica, 2004, (06) : 54 - 60
  • [4] UCN-01, a potent abrogator of G(2) checkpoint function in cancer cells with disrupted p53
    Wang, QZ
    Fan, SJ
    Eastman, A
    Worland, PJ
    Sausville, EA
    OConnor, PM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (14) : 956 - 965
  • [5] Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells: abrogation of S/G2 arrest
    Carleton B. Jones
    Mark K. Clements
    Safia Wasi
    Sayed S. Daoud
    Cancer Chemotherapy and Pharmacology, 2000, 45 : 252 - 258
  • [6] Enhancement of camptothecin-induced cytotoxicity with UCN-01 in breast cancer cells:: abrogation of S/G2 arrest
    Jones, CB
    Clements, MK
    Wasi, S
    Daoud, SS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 45 (03) : 252 - 258
  • [7] Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents
    Luo, Y
    Rockow-Magnone, SK
    Joseph, MK
    Bradner, J
    Butler, CC
    Tahir, SK
    Han, EKH
    Ng, SC
    Severin, JM
    Gubbins, EJ
    Reilly, RM
    Rueter, A
    Simmer, RL
    Holzman, TF
    Giranda, VL
    ANTICANCER RESEARCH, 2001, 21 (1A) : 23 - 28
  • [8] Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints
    Levesque, AA
    Kohn, EA
    Bresnick, E
    Eastman, A
    ONCOGENE, 2005, 24 (23) : 3786 - 3796
  • [9] Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpoints
    Aime A Levesque
    Ethan A Kohn
    Edward Bresnick
    Alan Eastman
    Oncogene, 2005, 24 : 3786 - 3796
  • [10] UCN-01 inhibits p53 up-regulation and abrogates γ-radiation-induced G2-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1
    Yu, Q
    La Rose, J
    Zhang, HL
    Takemura, H
    Kohn, KW
    Pommier, Y
    CANCER RESEARCH, 2002, 62 (20) : 5743 - 5748
123